Wells Fargo & Company Eli Lilly & CO Put Options Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $30 Million - $37.6 Million	41,400 Added 14.1%	335,100 $303 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $90.5 Million - $121 Million	152,800 Added 108.45%	293,700 $228 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $69.4 Million - $81.8 Million	132,200 Added 1519.54%	140,900 $82.1 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.17 Million - $1.62 Million	-2,700 Reduced 23.68%	8,700 $4.67 Million
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $1.26 Million - $1.69 Million	3,600 Added 46.15%	11,400 $5.35 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $2.14 Million - $2.52 Million	6,900 Added 766.67%	7,800 $2.68 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $2.93 Million - $3.41 Million	-9,100 Reduced 91.0%	900 $329,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.96 Million - $3.38 Million	10,000 New	10,000 $3.23 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $731,100 - $845,650	5,000 New	5,000 $5,000

3,872

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.